Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose.
M S RothS ChantraineC A Morales MatelunaKarin HartmannChristoph BergerPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)